skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Distinct expression profiles of Notch-1 protein in human solid tumors: Implications for development of targeted therapeutic monoclonal antibodies

Original Research

(2169) Views  (640) Full article downloads

Authors: Yuan Li, Janine A Burns, Carol A Cheney, et al

Published Date June 2010 Volume 2010:4 Pages 163 - 171
DOI: http://dx.doi.org/10.2147/BTT.S11021

Yuan Li1, Janine A Burns1, Carol A Cheney1, Ningyan Zhang1, Salvatore Vitelli1, Fubao Wang1, Andrew Bett2, Michael Chastain2, Laurent P Audoly1, Zhi-Qiang Zhang1,3

1Department of Biologics Research, 2Department of Vaccine Research, Merck Research Laboratories, West Point, PA, USA; 3Clinical Development Laboratory, Merck Research Laboratories, Rahway, NJ, USA

Abstract: Biological therapies, such as monoclonal antibodies (mAbs) that target tumor-associated antigens have been considered an effective therapeutic approach in oncology. In considering Notch-1 receptor as a potential target, we performed immunohistochemistry on tissue microarrays to determine 1) whether the receptor is overexpressed in tumor cells as compared to their corresponding normal tissues and 2) the clinical significance of its expression levels in human breast, colorectal, lung and prostate cancers. We found that the expression of Notch-1 protein was overexpressed in primary colorectal adenocarcinoma and nonsmall cell lung carcinoma (NSCLC), but not in primary ductal breast carcinoma or prostate adenocarcinoma. Further analysis revealed that higher levels of Notch-1 protein expression were significantly associated with poorer differentiation of breast and prostate tumors. Strikingly, for NSCLC, the expression levels of Notch-1 protein were found to be inversely correlated with tumor differentiation and progression. For colorectal tumors, however, no correlation of Notch-1 protein expression was found with any tumor clinicopathological parameters, in spite of its overexpression in tumor cells. Our data demonstrated the complexity of Notch-1 protein expression in human solid tumors and further supported the notion that the roles of Notch-1 expression in tumorigenesis are highly context-dependent. The findings could provide the basis for development of distinct therapeutic strategies of Notch-1 mAbs for its applications in the treatment of suitable types of human cancers.

Keywords: Notch-1, target therapy, tissue microarray, immunohistochemistry








Readers of this article also read:

Therapeutic vaccines for malignant brain tumors
Renin-angiotensin-aldosterone system in the elderly: rational use of aliskiren in managing hypertension
Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency
Safety of etanercept in elderly subjects with rheumatoid arthritis
Safety and immunogenicity of Salmonella typhimurium expressing C-terminal truncated human IL-2 in a murine model
Palliative treatment of malignant ascites: profile of catumaxomab
Managing idiopathic short stature: role of somatropin (rDNA origin) for injection
A retrospective database analysis of insulin use patterns in insulin-naïve patients with type 2 diabetes initiating basal insulin or mixtures
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
Using systematically observed clinical encounters (SOCEs) to assess medical students’ skills in clinical settings
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • Journal Indexing

    See where all the Dove Press journals are indexed